Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right – Business Wire

Your email address will not be published. Required fields are marked *

Save my name, email, and website in this browser for the next time I comment.

Δ